Find a Drug
Advanced Search

Professional

Vagistat-1

Indications & Dosage
font size

INDICATIONS

VAGISTAT-1 is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As VAGISTAT-1 has been shown to be effective only for candidal vulvovaginitis, the diagnosis should be confirmed by KOH smears and/or cultures. Other pathogens commonly associated with vulvovaginitis should be ruled out by appropriate methods.

Studies have shown that women taking oral contraceptives have a cure rate similar to those not taking such agents when treated with VAGISTAT-1.

Safety and effectiveness in pregnant and diabetic patients have not been established (see PRECAUTIONS).

DOSAGE AND ADMINISTRATION

VAGISTAT-1 has been found to be effective as a single- dose treatment for vulvovaginal candidiasis. Using the prefilled applicator, insert one applicator- full intravaginally. Administration of VAGISTAT-1 just prior to bedtime may be preferred.

HOW SUPPLIED

VAGISTAT-1 is supplied in a ready-to-use, prefilled, single-dose vaginal applicator (NDC 0087-0657-40). Each applicator-full will deliver approximately 4.6 grams of VAGISTAT-1 containing 65 mg of tioconazole per gram of ointment.

Storage: Store at controlled room temperature 15°-30° C (59°-86° F).

WARNING: Manufactured with 1,1,1-trichloroethane, a substance which harms public health and environment by destroying ozone in the upper atmosphere.

Brand Name: Vagistat-1
Generic Name: Tioconazole

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:


Women's Health

Find out what women really need.

WebMD Symptom Checker - Start Here Ringworm Slideshow: Watch and Learn

3D Mammogram3D Mammogram
Learn how new technology may change the way breast cancer is diagnosed and in turn, save more lives. See more WebMD Videos »